CASC

Cascadian Therapeutics

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cascadian Therapeutics Inc. market cap is N/A.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Cascadian Therapeutics Inc. 52 week high is N/A as of October 28, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cascadian Therapeutics Inc. 52 week low is N/A as of October 28, 2025.

Cascadian Therapeutics Inc. stock price today is $10.02.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cascadian Therapeutics Inc.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cascadian Therapeutics Inc. P/B ratio is None.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Cascadian Therapeutics Inc.'s EBITDA is N/A.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cascadian Therapeutics Inc. 50-day moving average is N/A.

Cascadian Therapeutics Inc. has 71 employees.